Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction.

Roux A, Leroy H, De Muylder B, Bracq L, Oussous S, Dusanter-Fourt I, Chougui G, Tacine R, Randriamampita C, Desjardins D, Le Grand R, Bouillaud F, Benichou S, Margottin-Goguet F, Cheynier R, Bismuth G, Mangeney M.

PLoS Pathog. 2019 May 1;15(5):e1007669. doi: 10.1371/journal.ppat.1007669. eCollection 2019 May.

2.

Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.

Dumas PY, Naudin C, Martin-Lannerée S, Izac B, Casetti L, Mansier O, Rousseau B, Artus A, Dufossée M, Giese A, Dubus P, Pigneux A, Praloran V, Bidet A, Villacreces A, Guitart A, Milpied N, Kosmider O, Vigon I, Desplat V, Dusanter-Fourt I, Pasquet JM.

Haematologica. 2019 Oct;104(10):2017-2027. doi: 10.3324/haematol.2018.205385. Epub 2019 Mar 28.

3.

PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.

Naudin C, Hattabi A, Michelet F, Miri-Nezhad A, Benyoucef A, Pflumio F, Guillonneau F, Fichelson S, Vigon I, Dusanter-Fourt I, Lauret E.

Blood. 2017 May 4;129(18):2493-2506. doi: 10.1182/blood-2016-10-747436. Epub 2017 Feb 23.

4.

Control of Pim2 kinase stability and expression in transformed human haematopoietic cells.

Adam K, Lambert M, Lestang E, Champenois G, Dusanter-Fourt I, Tamburini J, Bouscary D, Lacombe C, Zermati Y, Mayeux P.

Biosci Rep. 2015 Oct 23;35(6). pii: e00274. doi: 10.1042/BSR20150217.

5.

Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727.

Capron C, Jondeau K, Casetti L, Jalbert V, Costa C, Verhoeyen E, Massé JM, Coppo P, Béné MC, Bourdoncle P, Cramer-Bordé E, Dusanter-Fourt I.

Cell Death Dis. 2014 Oct 9;5:e1451. doi: 10.1038/cddis.2014.393. Erratum in: Cell Death Dis. 2015;6:e1627. Verhoyen, E [corrected to Verhoeyen, E].

6.

[STAT5, a new therapeutic target against the relapse of chronic myelogenous leukemia?].

Casetti L, Martin-Lannerée S, Najjar I, Dusanter-Fourt I.

Med Sci (Paris). 2013 Aug-Sep;29(8-9):693-5. doi: 10.1051/medsci/2013298005. Epub 2013 Sep 5. French. No abstract available.

7.

CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.

Astori A, Fredly H, Aloysius TA, Bullinger L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud Ø.

Oncotarget. 2013 Sep;4(9):1438-48.

8.

Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.

Casetti L, Martin-Lannerée S, Najjar I, Plo I, Augé S, Roy L, Chomel JC, Lauret E, Turhan AG, Dusanter-Fourt I.

Cancer Res. 2013 Apr 1;73(7):2052-8. doi: 10.1158/0008-5472.CAN-12-3955. Epub 2013 Feb 11.

9.

Cotargeting signaling pathways driving survival and cell cycle circumvents resistance to Kit inhibitors in leukemia.

Buet D, Gallais I, Lauret E, Denis N, Lombard B, Guillonneau F, Kosmider O, Loew D, Dusanter-Fourt I, Guillouf C, Mayeux P, Moreau-Gachelin F.

Blood. 2012 May 3;119(18):4228-41. doi: 10.1182/blood-2011-07-368316. Epub 2012 Mar 20.

PMID:
22438255
10.

A short Gfi-1B isoform controls erythroid differentiation by recruiting the LSD1-CoREST complex through the dimethylation of its SNAG domain.

Laurent B, Randrianarison-Huetz V, Frisan E, Andrieu-Soler C, Soler E, Fontenay M, Dusanter-Fourt I, Duménil D.

J Cell Sci. 2012 Feb 15;125(Pt 4):993-1002. doi: 10.1242/jcs.095877. Epub 2012 Mar 7.

11.

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Souissi I, Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, Roger C, Dusanter-Fourt I, Varin-Blank N, Cao A, Metelev V, Baran-Marszak F, Fagard R.

BMC Cell Biol. 2011 Apr 12;12:14. doi: 10.1186/1471-2121-12-14.

12.

STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?

Villalva C, Martin-Lannerée S, Cortes U, Dkhissi F, Wager M, Le Corf A, Tourani JM, Dusanter-Fourt I, Turhan AG, Karayan-Tapon L.

Int J Cancer. 2011 Feb 15;128(4):826-38. doi: 10.1002/ijc.25416.

13.

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.

Malamut G, El Machhour R, Montcuquet N, Martin-Lannerée S, Dusanter-Fourt I, Verkarre V, Mention JJ, Rahmi G, Kiyono H, Butz EA, Brousse N, Cellier C, Cerf-Bensussan N, Meresse B.

J Clin Invest. 2010 Jun;120(6):2131-43. doi: 10.1172/JCI41344. Epub 2010 May 3.

14.

STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient.

Najjar I, Deglesne PA, Schischmanoff PO, Fabre EE, Boisson-Dupuis S, Nimmerjahn F, Bornkamm GW, Dusanter-Fourt I, Fagard R.

J Leukoc Biol. 2010 Jun;87(6):1145-52. doi: 10.1189/jlb.1109714. Epub 2010 Mar 3.

PMID:
20200400
15.

High-mobility group protein HMGB2 regulates human erythroid differentiation through trans-activation of GFI1B transcription.

Laurent B, Randrianarison-Huetz V, Maréchal V, Mayeux P, Dusanter-Fourt I, Duménil D.

Blood. 2010 Jan 21;115(3):687-95. doi: 10.1182/blood-2009-06-230094. Epub 2009 Nov 24. Erratum in: Blood. 2010 Sep 2;116(9):1627. Marchal, Vincent [corrected to Maréchal, Vincent].

PMID:
19965638
16.

BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levels.

Coppo P, Dusanter-Fourt I, Vainchenker W, Turhan AG.

Cell Signal. 2009 Jan;21(1):52-60. doi: 10.1016/j.cellsig.2008.09.006. Epub 2008 Sep 19.

PMID:
18835438
17.

Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.

Harir N, Boudot C, Friedbichler K, Sonneck K, Kondo R, Martin-Lannerée S, Kenner L, Kerenyi M, Yahiaoui S, Gouilleux-Gruart V, Gondry J, Bénit L, Dusanter-Fourt I, Lassoued K, Valent P, Moriggl R, Gouilleux F.

Blood. 2008 Sep 15;112(6):2463-73. doi: 10.1182/blood-2007-09-115477. Epub 2008 Jun 25. Erratum in: Blood. 2009 Aug 20;114(8):1720.

18.

[Nef and PPAR-gamma interact to suppress Stat5 expression in CD34+ progenitors from infected macaques].

Prost S, Le Dantec M, Augé S, Le Grand R, Derdouch S, Auregan G, Déglon N, Relouzat F, Aubertin AM, Maillere B, Dusanter-Fourt I, Kirszenbaum M.

Med Sci (Paris). 2008 May;24(5):551-3. doi: 10.1051/medsci/2008245551. French. No abstract available.

19.

Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques.

Prost S, Le Dantec M, Augé S, Le Grand R, Derdouch S, Auregan G, Déglon N, Relouzat F, Aubertin AM, Maillere B, Dusanter-Fourt I, Kirszenbaum M.

J Clin Invest. 2008 May;118(5):1765-75. doi: 10.1172/JCI33037.

20.

STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma.

Ritz O, Guiter C, Dorsch K, Dusanter-Fourt I, Wegener S, Jouault H, Gaulard P, Castellano F, Möller P, Leroy K.

Leukemia. 2008 Nov;22(11):2106-10. doi: 10.1038/leu.2008.85. Epub 2008 Apr 10. No abstract available.

PMID:
18401415
21.

Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway.

Aoudjehane L, Podevin P, Scatton O, Jaffray P, Dusanter-Fourt I, Feldmann G, Massault PP, Grira L, Bringuier A, Dousset B, Chouzenoux S, Soubrane O, Calmus Y, Conti F.

FASEB J. 2007 May;21(7):1433-44. Epub 2007 Feb 5.

PMID:
17283223
22.

[Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].

Espert L, Dusanter-Fourt I, Chelbi-Alix MK.

Bull Cancer. 2005 Oct;92(10):845-57. French.

23.

Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndrome.

Bénit L, Cramer EM, Massé JM, Dusanter-Fourt I, Favier R.

J Thromb Haemost. 2005 Sep;3(9):2077-80.

24.

IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity.

Rouyez MC, Lestingi M, Charon M, Fichelson S, Buzyn A, Dusanter-Fourt I.

J Immunol. 2005 Apr 1;174(7):3948-58.

25.

Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells.

Baran-Marszak F, Feuillard J, Najjar I, Le Clorennec C, Béchet JM, Dusanter-Fourt I, Bornkamm GW, Raphaël M, Fagard R.

Blood. 2004 Oct 15;104(8):2475-83. Epub 2004 Jun 24.

PMID:
15217838
26.
27.

Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.

Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, Gaulard P, Leroy K, Castellano F.

Blood. 2004 Jul 15;104(2):543-9. Epub 2004 Mar 25.

PMID:
15044251
28.

STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression.

Magné S, Caron S, Charon M, Rouyez MC, Dusanter-Fourt I.

Mol Cell Biol. 2003 Dec;23(24):8934-45.

29.

Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.

Coppo P, Dusanter-Fourt I, Millot G, Nogueira MM, Dugray A, Bonnet ML, Mitjavila-Garcia MT, Le Pesteur D, Guilhot F, Vainchenker W, Sainteny F, Turhan AG.

Oncogene. 2003 Jun 26;22(26):4102-10.

PMID:
12821944
30.

Forced expression of p21 in GPIIb-p21 transgenic mice induces abnormalities in the proliferation of erythroid and megakaryocyte progenitors and primitive hematopoietic cells.

Albanese P, Chagraoui J, Charon M, Cocault L, Dusanter-Fourt I, Romeo PH, Uzan G.

Exp Hematol. 2002 Nov;30(11):1263-72.

PMID:
12423679
31.

The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells.

Challier C, Cocault L, Berthier R, Binart N, Dusanter-Fourt I, Uzan G, Souyri M.

Blood. 2002 Sep 15;100(6):2063-70.

PMID:
12200367
32.

Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.

Fagard R, Mouas H, Dusanter-Fourt I, Devillers C, Bissières P, Martin A, Lenoir G, VanTan H, Feuillard J, Raphaël M.

Oncogene. 2002 Jul 4;21(29):4473-80.

33.

BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressing a carboxyl-terminal truncated STAT5.

Ahmed M, Dusanter-Fourt I, Dugray A, Dubrez L, Novault S, Bonnet ML, Gisselbrecht S, Varet B, Solary E, Vainchenker W, Turhan AG.

Leuk Lymphoma. 2001 Jul;42(3):445-55.

PMID:
11699409
34.

Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo).

Bouscary D, Lecoq-Lafon C, Chrétien S, Zompi S, Fichelson S, Muller O, Porteu F, Dusanter-Fourt I, Gisselbrecht S, Mayeux P, Lacombe C.

Oncogene. 2001 Apr 26;20(18):2197-204.

35.

Cell swelling activates STAT1 and STAT3 proteins in cultured rat hepatocytes.

Meisse D, Dusanter-Fourt I, Husson A, Lavoinne A.

FEBS Lett. 1999 Dec 17;463(3):360-4.

36.

Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells : synergy with interleukin-1beta.

Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S, Créminon C, Staels B, Maclouf J, Tedgui A.

Circ Res. 1999 Dec 3-17;85(12):1124-31.

PMID:
10590238
37.

Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.

Taksin AL, Couedic JP, Dusanter-Fourt I, Massé A, Giraudier S, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N.

Blood. 1999 Jan 1;93(1):125-39.

PMID:
9864154
38.

Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.

Starck J, Doubeikovski A, Sarrazin S, Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter-Fourt I, Morle F.

Mol Cell Biol. 1999 Jan;19(1):121-35.

39.

Molecular pathophysiology of chronic myelogenous leukemia.

Turhan AG, Solary E, Vainchenker W, Dusanter-Fourt I.

Hematol Cell Ther. 1998 Oct;40(5):217-21. Review.

PMID:
9844814
40.

BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.

Ahmed M, Dusanter-Fourt I, Bernard M, Mayeux P, Hawley RG, Bennardo T, Novault S, Bonnet ML, Gisselbrecht S, Varet B, Turhan AG.

Oncogene. 1998 Jan 29;16(4):489-96.

41.
42.

Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1/Spi-1 in UT7-Mpl cells.

Doubeikovski A, Uzan G, Doubeikovski Z, Prandini MH, Porteu F, Gisselbrecht S, Dusanter-Fourt I.

J Biol Chem. 1997 Sep 26;272(39):24300-7.

43.

Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Rouyez MC, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F.

Mol Cell Biol. 1997 Sep;17(9):4991-5000.

44.

The prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitors.

Socolovsky M, Dusanter-Fourt I, Lodish HF.

J Biol Chem. 1997 May 30;272(22):14009-12.

45.

Ectopic expression of the erythropoietin receptor in a murine interleukin-6-dependent plasmacytoma cell line (TEPC-2027) confers proliferative responsiveness to erythropoietin.

Féger F, Dubart A, Lacout C, Dusanter-Fourt I, Mayeux P, Vainchenker W, Duménil D.

Blood. 1997 Jan 15;89(2):435-45.

PMID:
9002945
46.

A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.

Jousset C, Carron C, Boureux A, Quang CT, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J.

EMBO J. 1997 Jan 2;16(1):69-82.

47.

Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation.

Gobert S, Chretien S, Gouilleux F, Muller O, Pallard C, Dusanter-Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P.

EMBO J. 1996 May 15;15(10):2434-41.

48.

Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.

Porteu F, Rouyez MC, Cocault L, Bénit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I.

Mol Cell Biol. 1996 May;16(5):2473-82.

49.

STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients.

Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L.

Blood. 1996 Mar 1;87(5):1692-7.

PMID:
8634413
50.

Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction.

Gobert S, Porteu F, Pallu S, Muller O, Sabbah M, Dusanter-Fourt I, Courtois G, Lacombe C, Gisselbrecht S, Mayeux P.

Blood. 1995 Jul 15;86(2):598-606.

PMID:
7541671

Supplemental Content

Loading ...
Support Center